These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effects of eplerenone versus losartan in patients with low-renin hypertension. Weinberger MH; White WB; Ruilope LM; MacDonald TM; Davidson RC; Roniker B; Patrick JL; Krause SL Am Heart J; 2005 Sep; 150(3):426-33. PubMed ID: 16169319 [TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats. Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572 [TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid receptor antagonists and endothelial function. Maron BA; Leopold JA Curr Opin Investig Drugs; 2008 Sep; 9(9):963-9. PubMed ID: 18729003 [TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone. Hu X; Li S; McMahon EG; Lala DS; Rudolph AE Mini Rev Med Chem; 2005 Aug; 5(8):709-18. PubMed ID: 16101407 [TBL] [Abstract][Full Text] [Related]
12. A Comparison of Adrenalectomy and Eplerenone on Vascular Function in Patients with Aldosterone-producing Adenoma. Kishimoto S; Oki K; Maruhashi T; Kajikawa M; Hashimoto H; Takaeko Y; Harada T; Yamaji T; Han Y; Kihara Y; Chayama K; Goto C; Yusoff FM; Nakashima A; Higashi Y J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32818224 [TBL] [Abstract][Full Text] [Related]
13. Acute effect of mineralocorticoid receptor antagonism on vascular function in healthy older adults. Hwang MH; Yoo JK; Luttrell M; Kim HK; Meade TH; English M; Talcott S; Jaffe IZ; Christou DD Exp Gerontol; 2016 Jan; 73():86-94. PubMed ID: 26639352 [TBL] [Abstract][Full Text] [Related]
14. Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway. Kobayashi N; Hara K; Tojo A; Onozato ML; Honda T; Yoshida K; Mita S; Nakano S; Tsubokou Y; Matsuoka H Hypertension; 2005 Apr; 45(4):538-44. PubMed ID: 15710785 [TBL] [Abstract][Full Text] [Related]
16. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure. Moore TD; Nawarskas JJ; Anderson JR Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934 [TBL] [Abstract][Full Text] [Related]
17. Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension. Sato A; Fukuda S J Hum Hypertens; 2010 Jun; 24(6):387-94. PubMed ID: 19865106 [TBL] [Abstract][Full Text] [Related]